Surevin IPO vs Vaishali Pharma IPO

Comparision between Surevin IPO and Vaishali Pharma IPO.

IPO Details

Surevin IPO is a SME Book Built Issue IPO proposed to list at NSE SME while Vaishali Pharma IPO is a SME Book Built Issue proposed to list at NSE SME.

	Surevin IPO	Vaishali Pharma IPO
Logo
Issue Category	SME	SME
Issue Type	IPO	IPO
Process Type	Book Built Issue	Book Built Issue
Listing At	NSE SME	NSE SME
Lead Managers	Hem Securities Limited	Pantomath Capital Advisors Pvt Ltd
Registrar	Sharex Dynamic (India) Pvt Ltd	Bigshare Services Pvt Ltd
Market Maker
DRHP	DRHP	DRHP
RHP	RHP	RHP
Anchor Investor
IPO Allotment URL	IPO Allotment URL

Issue Size and Price

The total issue size of Surevin IPO is up to ₹3.65 Cr whereas the issue size of the Vaishali Pharma IPO is up to ₹14.23 Cr. The final issue price of Surevin IPO is ₹40.00 per share and of Vaishali Pharma IPO is ₹72.00 per share.

	Surevin IPO	Vaishali Pharma IPO
Face Value	₹10 per share	₹10 per share
Issue Price (Lower)	₹38.00 per share	₹71.00 per share
Issue Price (Upper)	₹40.00 per share	₹72.00 per share
Issue Price (Final)	₹40.00 per share	₹72.00 per share
Discount (Retail)
Discount (Employee)
Market Lot Size	3000 shares	1600 shares
Fresh Issue Size
Fresh Issue Size (Amount)
OFS Issue Size
OFS Issue Size (Amount)
Issue Size Total	9,12,000 shares	19,76,000 shares
Issue Size Total (Amount)	up to ₹3.65 Cr	up to ₹14.23 Cr

IPO Timetable

Surevin IPO opens on Jul 28, 2017, while Vaishali Pharma IPO opens on Aug 07, 2017. The closing date of Surevin IPO and Vaishali Pharma IPO is Aug 01, 2017, and Aug 10, 2017, respectively.

	Surevin IPO	Vaishali Pharma IPO
Anchor Bid Date
Issue Open	Jul 28, 2017	Aug 07, 2017
Issue Close	Aug 01, 2017	Aug 10, 2017
Basis Of Allotment (Tentative)
Initiation of Refunds (Tentative)
Credit of Share (Tentative)
Listing date (Tentative)
Anchor Lockin End date 1
Anchor Lockin End date 2

Financials

Surevin IPO P/E ratio is , as compared to Vaishali Pharma IPO P/E ratio of .

Surevin IPO

Vaishali Pharma IPO

Financial

Summary of financial Information (Consolidated)
Particulars	For the year/period ended (in Rs. Lakhs)
	31-Mar-17	31-Mar-16	31-Mar-15	31-Mar-14	31-Mar-13
Total Assets	4464.87	4941.31	4579.50	5342.97	4858.17
Total Revenue	6711.22	6989.13	9882.37	12156.90	11909.85
Profit After Tax	66.37	(3.03)	16.15	30.05	60.00

Promoter Shareholding (Pre-Issue)

Promoter Shareholding (Post-Issue)

P/E Ratio

Market Cap

ROE

ROCE

Debt/Equity

EPS

RoNW

Shares Offered

In the Surevin IPO retail investors (RII) are offered 4,56,000 shares while in Vaishali Pharma IPO retail investors are offered 4,56,000 shares. Qualified institutional buyers (QIB) are offered 0 shares in Surevin IPO and 0 shares in Vaishali Pharma IPO.

	Surevin IPO	Vaishali Pharma IPO
Anchor Investor Reserveration
Market Maker Reserveration
QIB	0 shares	0 shares
NII	4,56,000 shares	9,88,000 shares
RII	4,56,000 shares	9,88,000 shares
Employee
Others
Total	9,12,000 shares	19,76,000 shares

Bids Received (Subscription)

Surevin IPO subscribed 55.38x in total, whereas Vaishali Pharma IPO subscribed 1.89x.

	Surevin IPO	Vaishali Pharma IPO
QIB (times)
NII (times)	75.12x	1.87x
Big NII (times)
Small NII (times)
RII (times)	34.89x	1.91x
Employee (times)
Other (times)
Total (times)	55.38x	1.89x

Compare with others

Surevin IPO	Vaishali Pharma IPO
Lexus Granito IPO	Shish Industries IPO
Geekay Wires IPO	Lexus Granito IPO
Servotech Power IPO	Geekay Wires IPO
Ashok Masala IPO	Servotech Power IPO
Vaishali Pharma IPO	Ashok Masala IPO
Global Space IPO	Surevin IPO
Total Transport IPO	Global Space IPO
Captain Technocast IPO	Total Transport IPO
Keerti Knowledge IPO	Captain Technocast IPO
Shanti Overseas IPO	Keerti Knowledge IPO

Comments

Add a public comment...